More Groups
Fewer Groups
More People
Fewer People
More Years
Fewer Years
More Publications
Fewer Publications
Sheikh, R.; Truong, H.; Kotecha, R.; Kemel, Y.; Khurram, A.; Vijay, J.; Mandelker, D.; Ceyhan-Birsoy, O.; Latham, A.; Walsh, M.; more... Molecular Genetics and Metabolism (2021)
Rodriguez Barreto, A. M.; Cunniff, C.; Ellis, N.; Flanagan, M. Molecular Genetics and Metabolism (2021)
Javdani, N.; Ho, J. Q.; Arabi, L.; Le, A.; Ghegeliu, D.; Aieneravaie, M.; Georgala, P.; Sepand, M. R.; Rafat, M.; Zanganeh, S. In Mahmoudi, M. (Eds.) Nanomedicine for Ischemic Cardiomyopathy: Progress, Opportunities, and Challenges (2020)
Aieneravaie, M.; Ho, J. Q.; Arabi, L.; Kim, A.; Liang, S.; Jones, S.; Javdani, N.; Georgala, P.; Sepand, M. R.; Rafat, M.; more... In Mahmoudi, M. (Eds.) Nanomedicine for Ischemic Cardiomyopathy: Progress, Opportunities, and Challenges (2020)
Arabi, L.; Ho, J. Q.; Javdani, N.; Sharaf, M.; Lam, M.; Aieneravaie, M.; Georgala, P.; Sepand, M. R.; Rafat, M.; Zanganeh, S. In Mahmoudi, M. (Eds.) Nanomedicine for Ischemic Cardiomyopathy: Progress, Opportunities, and Challenges (2020)
Arabi, L.; Ho, J. Q.; Javdani, N.; Jones, S.; Chen, I.; Sharaf, M.; Aieneravaie, M.; Georgala, P.; Sepand, M. R.; Rafat, M.; more... In Mahmoudi, M. (Eds.) Nanomedicine for Ischemic Cardiomyopathy: Progress, Opportunities, and Challenges (2020)
Nikolov, D. B.; Himanen, J. P. In Freywald, A.; Vizeacoumar, F. J. (Eds.) Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (2020)
Aieneravaie, M.; Ho, J. Q.; Arabi, L.; Lee, J.; Herrera, K.; Mehreen, S.; Javdani, N.; Georgala, P.; Sepand, M. R.; Rafat, M.; more... In Mahmoudi, M. (Eds.) Nanomedicine for Ischemic Cardiomyopathy: Progress, Opportunities, and Challenges (2020)
Bhatt, V.; Scordo, M.; Carlow, D. C. In Ketha, H.; Garg, U. (Eds.) Toxicology Cases for the Clinical and Forensic Laboratory (2020)
Zhang, X.; Das, S.; Dunbar, S.; Tang, Y. W. Advances in Clinical Chemistry (2020)